It is also not recommended for patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2, due to thyroid C-cell tumor risk observed in animal studies
At AgeWell Medicine & Aesthetics, we offer semaglutide, a medication belonging to the GLP-1 (glucagon-like peptide-1) receptor agonist class
The headlines
Game Changing Weight Loss Qualified patients receive a GLP-1 prescription (like Ozempic or Wegovy or Semaglutide) to shed excess weight* with little effort
GLP-1 receptors are present in various tissues throughout the body, including pancreatic beta cells, the gastrointestinal tract, and the brain
Ristoff, E., Hebert, C., Njalsson, R., Norgren, S., Rooyackers, O